Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: a microdialysis study.
Orexinergic neurons are discretely localized within the lateral hypothalamus and have widespread projections to the whole brain. Here, the role of orexin/hypocretin-2 receptors (OX2) in modulating extracellular concentrations of neurotransmitters was evaluated in the hypothalamus and the prefrontal cortex (PFC) of OX2 knockout (KO) mice by using a microdialysis technique. In the hypothalamus, basal concentrations of norephinephrine (NE), acetylcholine (ACh), and histamine (Hist) were significantly higher in KO mice, whereas KCl perfusion (147 mM) resulted in significantly lesser increases in NE, ACh, and Hist release in KO compared with wild-type (WT) mice. No differences in basal concentrations or evoked release of serotonin (5-HT) or dopamine (DA) were found in the hypothalamus between genotypes. In the PFC, no differences in the basal concentrations of the studied neurotransmitters were found between genotypes. After KCl perfusion, significantly higher increases in NE, 5-HT, and DA release were found in KO compared with WT mice. No differences in the evoked release of ACh and Hist in the PFC were found between genotypes. The present results demonstrate that genetic deletion of OX2 receptors differentially modulates extracellular concentrations of distinct neurotransmitters in the somatodendritic region vs. a nerve terminal region of the orexinergic neurons. In the hypothalamus, an inhibitory role of the OX2 receptors in modulating basal concentrations of NE, ACh, and Hist was revealed, which probably accounts for the reduced responsiveness to KCl as well. In the PFC, the evoked release of the monoamines NE, 5-HT, and DA seems to be controlled negatively by OX2 receptors.
Eli Lilly and Co., Indianapolis, Indiana 46240-0510, USA. jorge.ortega@ehu.es
Jorge E
JE
Ortega
Jason
J
Katner
Richard
R
Davis
Mark
M
Wade
Laura
L
Nisenbaum
George G
GG
Nomikos
Kjell A
KA
Svensson
Kenneth W
KW
Perry
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D004298:Dopamine / Q000378:metabolism; D006632:Histamine / Q000378:metabolism; D007031:Hypothalamus / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D017551:Microdialysis; D009638:Norepinephrine / Q000378:metabolism; D064446:Orexin Receptors; D017397:Prefrontal Cortex / Q000502:physiology*; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*; D018013:Receptors, Neuropeptide / Q000235:genetics / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D009435:Synaptic Transmission / Q000235:genetics / Q000502:physiology*
D064446:Orexin Receptors; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D012701:Serotonin; D006632:Histamine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine